ipriflavone has been researched along with Inflammation in 4 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study aimed at evaluating the ameliorative effects of ipriflavone (IP) as a natural food supplement on lipid metabolism, improving insulin sensitivity, reducing oxidative stress and inflammation, modifying metabolic risk factors and/or reduce brain damage, in both neonates and their dams." | 8.02 | Evaluation of Insulin Resistance Induced Brain Tissue Dysfunction in Obese Dams and their Neonates: Role of Ipriflavone Amelioration. ( Abdel-Reheim, ES; Abuelsaad, ASA; Gad, RA; Hafez, HS; Shehab, GMG, 2021) |
| "The aim of the present study was to formulate and evaluate ipriflavone loaded albumin nanoparticles (IP-Np) along with free ipriflavone against lipopolysaccharide (LPS) induced neuroinflammation in rats." | 7.96 | Ipriflavone and Ipriflavone loaded albumin nanoparticles reverse lipopolysaccharide induced neuroinflammation in rats. ( El Demellawy, MA; El-Sayed, MM; Ghareeb, DA; Khalil, S; Saleh, SR; Yassa, NW, 2020) |
| " The present study aimed at evaluating the ameliorative effects of ipriflavone (IP) as a natural food supplement on lipid metabolism, improving insulin sensitivity, reducing oxidative stress and inflammation, modifying metabolic risk factors and/or reduce brain damage, in both neonates and their dams." | 4.02 | Evaluation of Insulin Resistance Induced Brain Tissue Dysfunction in Obese Dams and their Neonates: Role of Ipriflavone Amelioration. ( Abdel-Reheim, ES; Abuelsaad, ASA; Gad, RA; Hafez, HS; Shehab, GMG, 2021) |
| "The aim of the present study was to formulate and evaluate ipriflavone loaded albumin nanoparticles (IP-Np) along with free ipriflavone against lipopolysaccharide (LPS) induced neuroinflammation in rats." | 3.96 | Ipriflavone and Ipriflavone loaded albumin nanoparticles reverse lipopolysaccharide induced neuroinflammation in rats. ( El Demellawy, MA; El-Sayed, MM; Ghareeb, DA; Khalil, S; Saleh, SR; Yassa, NW, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Gad, RA | 1 |
| Abdel-Reheim, ES | 1 |
| Shehab, GMG | 1 |
| Hafez, HS | 1 |
| Abuelsaad, ASA | 1 |
| Yassa, NW | 1 |
| Khalil, S | 1 |
| Saleh, SR | 1 |
| Ghareeb, DA | 1 |
| El Demellawy, MA | 1 |
| El-Sayed, MM | 1 |
| Seaver, B | 1 |
| Smith, JR | 1 |
4 other studies available for ipriflavone and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Evaluation of Insulin Resistance Induced Brain Tissue Dysfunction in Obese Dams and their Neonates: Role of Ipriflavone Amelioration.
Topics: Animals; Brain; Female; Inflammation; Insulin Resistance; Isoflavones; Obesity; Oxidative Stress; Ra | 2021 |
Ipriflavone and Ipriflavone loaded albumin nanoparticles reverse lipopolysaccharide induced neuroinflammation in rats.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Animals; Cholinesterase Inhibitors; Cytokines; Drug Del | 2020 |
Inhibition of COX isoforms by nutraceuticals.
Topics: Biflavonoids; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibi | 2004 |